AemetisAMTX +6.87%50 EBITDA Margin % is -14.33% as of Mar. 2026. GuruFocus rates AMTX with a GF Score™ of 50/100 and a GF Value™ of $2.11 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,585 Chemicals companies, Aemetis ranks worse than 90.79% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Aemetis's EBITDA for the
three
months ended in Mar. 2026 was $-7.8 Mil. Aemetis's Revenue for the
three
months ended in Mar. 2026 was $54.6 Mil. Therefore, Aemetis's EBITDA margin for the quarter that ended in Mar. 2026 was -14.33%.
Aemetis (NAS:AMTX) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Aemetis EBITDA Margin % Related Terms
Aemetis EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Aemetis's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Aemetis's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aemetis EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Aemetis's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Aemetis's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aemetis (AMTX) has a EBITDA Margin % of -14.33% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aemetis and its competitors. According to the industry distribution chart, Aemetis ranks #1439 out of 1585 companies in the Chemicals industry, placing it in the top 90.8%.
Is Aemetis' EBITDA Margin % too high?
Aemetis' current EBITDA Margin % is -14.33%. Based on the distribution chart, Aemetis ranks #1439 out of 1585 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Aemetis has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aemetis' EBITDA Margin % compare to FF and RLEA?
According to the Chemicals industry distribution chart, Aemetis ranks #1439 out of 1585 companies for EBITDA Margin %. This places Aemetis in the lower half of its industry. The industry median EBITDA Margin % is 9.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aemetis and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aemetis's current EBITDA Margin % is -14.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aemetis stock overvalued right now?
Based on GuruFocus' analysis, Aemetis (AMTX) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.11, compared to a current price of $1.69 — trading 19.9% below its estimated fair value. The current EBITDA Margin % is -14.33%. Aemetis' overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Aemetis (AMTX), the current EBITDA Margin % is -14.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aemetis (AMTX) Overvalued in 2026?
Based on GuruFocus' analysis, Aemetis stock appears to be undervalued.
The current stock price of $1.69 is trading 19.9% below its estimated GF Value™ of $2.11.
GuruFocus considers Aemetis to be Modestly Undervalued.
Key valuation signals for AMTX:
EBITDA Margin %: -14.33%
GF Value™: $2.11 vs. price of $1.69 (19.9% below fair value)
No single metric tells the full story. See the AMTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.
50GF Score
Get the complete analysis for AMTX
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMTX has been successfully added to your 
